DYMEF - DionyMed Brands Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0670
-0.0010 (-1.47%)
As of 10:22AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.0680
Open0.0620
BidN/A x N/A
AskN/A x N/A
Day's Range0.0600 - 0.0776
52 Week Range0.0550 - 3.2100
Volume4,678
Avg. Volume172,182
Market Cap2.438M
Beta (3Y Monthly)10.68
PE Ratio (TTM)N/A
EPS (TTM)-1.5150
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire

    Flow Capital Announces Legal Proceedings Against Dionymed

    TORONTO, Sept. 23, 2019 -- Flow Capital Corp. (TSXV: FW) (the “Company”) announced today that it has commenced legal proceedings against Dionymed Brands Inc. (CSE: DYME; OTCQB:.

  • Business Wire

    DionyMed Brands Provides Financing Update, Announces Reorganization and Resumption of Trading

    OTCQB:DYMEF), a multi-state cannabis brands, Direct-to-Consumer and distribution platform, today announced additional investment from its senior secured investor of US$3.2MM and a reorganization of the business to right size the Company. This increases the credit facility with the senior lender to US$19.2 MM. While the credit facility is currently in default, the senior lender has agreed to make additional advances to the Company.

  • Business Wire

    DionyMed Brands Announces Organizational Update, Trading Halt

    OTCQB:DYMEF), a multi-state cannabis brands, Direct-to-Consumer and distribution platform, today announced trading of the Company’s shares was halted on September 16, 2019 pending an agreement for a restructuring of its debt facility. The Company expects to provide details of such restructuring very shortly. Mark Zinselmeier, a consultant with the Company, who had been working with DionyMed on growing its Chill Direct-to-Consumer cannabis delivery service, has been named interim COO.

  • Business Wire

    DionyMed Scores Victory in Eaze Payment Processing Lawsuit

    OTCQB: DYMEF), a multi-state cannabis brands, direct-to-consumer and distribution platform, achieved a victory yesterday in its unfair competition lawsuit against Eaze Technologies, Inc. (“Eaze”) by defeating Eaze’s motion to dismiss Herban’s complaint. On June 4, 2019, Herban filed suit in the California Superior Court for the County of San Francisco against Eaze seeking an injunction to halt Eaze’s processing of credit and debit cards through its website and mobile application.

  • OTC Markets Group Announces Quarterly Index Performance and Rebalancing
    PR Newswire

    OTC Markets Group Announces Quarterly Index Performance and Rebalancing

    NEW YORK , July 11, 2019 /PRNewswire/ --   OTC Markets Group Inc.  (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the second quarter 2019 performance ...

  • Benzinga

    What To Know About The DionyMed-Eaze Lawsuit

    Earlier this week, a subsidiary of DionyMed Brands Inc. (OTC: DYMEF) filed a lawsuit against Eaze Technologies, Inc. in the California Superior Court for the County of San Francisco. The former is pursuing an injunction to stop Eaze’s alleged processing of credit and debit cards through its website and app.

  • Business Wire

    DionyMed Brands Inc. Announces Investment Agreement for up to CAD$32 Million with Alumina Partners

    OTCQB: DYMEF), a multi-state cannabis brands, distribution and direct-to-consumer delivery platform, today announced that it has entered into an investment agreement (the “Agreement”) with Alumina Partners (Ontario) Ltd. (“Alumina”) providing availability of up to CAD$32 million over a 24-month period, to provide funding for the expansion of the Company’s leading cannabis product portfolio into new growth markets. Under the terms of the Agreement, DionyMed will sell, on a private placement basis completed in tranches, units of the Company with a total value of up to CAD$2 million per tranche, over a 24-month period. Each unit consists of one subordinate voting share (each, a “Subordinate Voting Share”) and one half of one Subordinate Voting Share purchase warrant (each, a “Warrant”) in the capital of DionyMed.

  • CNW Group

    Cannabis Virtual Investor Conference Presentations Now Available for On-Demand Viewing

    Cannabis Virtual Investor Conference Presentations Now Available for On-Demand Viewing

  • Business Wire

    DionyMed Subsidiary Sues to Stop Eaze Credit Card Processing

    Herban Industries CA LLC (“Herban”) today filed suit in the California Superior Court for the County of San Francisco against Eaze Technologies, Inc. (“Eaze”) seeking an injunction to halt Eaze’s processing of credit and debit cards through its website and app. The complaint alleges that “to gain an unfair competitive advantage in the California cannabis delivery market, Eaze is directing, coordinating, and participating in a scheme to defraud credit card companies and financial institutions into processing cannabis transactions in violation of a host of criminal laws,” including prohibitions against wire fraud and bank fraud. As relief, the complaint seeks an injunction to halt Eaze’s credit and debit card processing and an end to its unfair competition against Chill, DionyMed’s direct-to-consumer platform.

  • Business Wire

    DionyMed Brands Inc. Announces Restatement of Certain Historical Financial Statements for Prior Fiscal Period Ended February 28, 2018

    DionyMed Brands Inc. , a multi-state cannabis brands, distribution and direct-to-consumer delivery platform, announced today that due to a change in application of an accounting treatment, its predecessor corporation, DionyMed Holdings Inc., has completed and filed the restatement of its audited financial statements for the periods ended February 28, 2018 and July 31, 2018, and the interim quarters ...

  • Business Wire

    DionyMed Brands Inc. CEO Edward Fields to Participate on Panel at the Piper Jaffray 39th Annual Consumer Marketplace Conference

    OTCQB: DYMEF), a multi-state cannabis brands, distribution and direct-to-consumer delivery platform, today announced that the Company will participate at Piper Jaffray’s 39th Annual Consumer Marketplace Conference on June 6, 2019, at The Pierre hotel in New York City. DionyMed’s Chief Executive Officer, Edward Fields, is scheduled to participate in the “Connecting with U.S. Consumers: Retail & Online Delivery” panel discussion from 11:00 a.m. to 11:45 a.m. ET and will be available for one-on-one meetings throughout the day of the conference. “Cannabis continues its evolution into a mainstream consumer packaged goods product and our inclusion at the Piper Jaffray CPG conference is evidence of our expanding position,” stated DYME CEO Edward Fields.

  • Benzinga

    Canaccord: DionyMed On Track For 'Strong' 2020

    Bobby Burleson maintained a Speculative Buy rating on DionyMed's Canada-listed stock with an unchanged CA$6 ($4.46) price target. Need more cannabis news? DionyMed reported revenue of CA$14.4 million and an EBITDA loss of CA$6.5 million in the first quarter, missing expectations of CA$19.3 million in revenue and a CA$4.8-million EBITDA loss, Burleson said in a Sunday note.

  • PR Newswire

    DionyMed Brands, Inc. to Webcast Live at VirtualInvestorConferences.com June 4th

    Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com TORONTO , June 3, 2019 /PRNewswire/ ...

  • Business Wire

    DionyMed Brands Inc. Reports Fourth Quarter and Fiscal-Year 2018 Financial Results

    DionyMed Brands Inc. (“DionyMed” or the “Company”) (DYME.CN) (DYMEF), a multi-state cannabis brands, distribution and delivery platform, announced today its consolidated financial results for the fourth quarter and its audited financial results for the fiscal year ended December 31, 2018. The Distribution business distributes and sells to over 875 retail dispensaries in California and Oregon.

  • CNW Group

    Live Investor Conference & Webinar: Cannabis Industry Companies Present June 4th

    Live Investor Conference & Webinar: Cannabis Industry Companies Present June 4th

  • Business Wire

    DionyMed Brands Inc. Announces First Quarter 2019 Financial Results and Provides Financial Outlook for the Second Quarter of 2019

    DionyMed Brands Inc. (“DionyMed”, “DYME” or the “Company”) (DYME.CN) (DYMEF), a multi-state cannabis brands, distribution and direct-to-consumer delivery platform, announced today its financial and operational results for its first fiscal quarter of 2019. The Distribution business distributes and sells to over 900 retail dispensaries in California and Oregon. The Direct-to-Consumer platform sells products online and delivers directly to customers.

  • Business Wire

    DionyMed Brands Inc. to Participate in the Canaccord Genuity Cannabis Conference on May 14

    DionyMed Brands Inc. , a multi-state cannabis brands, distribution and delivery platform, today announced that Edward Fields, Chief Executive Officer of DionyMed Brands Inc., will present at the Canaccord Genuity 3rd Annual Cannabis Conference to be held at the Grand Hyatt New York in New York, NY on Tuesday, May 14, 2019 at 1:40pm ET.

  • Business Wire

    DionyMed Brands Inc. Signs Exclusive Distribution Agreement with CBD Alive

    OTCQB:DYMEF), a multi-state cannabis brands, distribution and delivery platform, announced today an exclusive distribution agreement with CBD Alive to expand the Company’s award-winning cannabis brand portfolio with one of California’s highest-quality, premium CBD product lines. “CBD is the fastest growing market segment within the cannabis industry and DionyMed is committed to partnering with brands that offer the highest-quality and safest products for our customers.